Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Hutchmed (HCM) Share Price

Price 221.00p on 03-12-2025 at 05:12:21
Change 0.00p 0%
Buy 221.00p
Sell 218.00p
Last Trade: Buy 130.00 at 221.00p
Day's Volume: 0
Last Close: 221.00p
Open: 0.00p
ISIN: KYG4672N1198
Day's Range 0.00p - 0.00p
52wk Range: 187.50p - 292.00p
Market Capitalisation: £1.90b
VWAP: 0.00p
Shares in Issue: 859.36m

Hutchmed (HCM) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 130 221.00p Suspected BUY Trade
16:35:28 - 02-Dec-25
Buy* 1 220.94p Ordinary
15:55:10 - 02-Dec-25
Sell* 7,250 219.40p Ordinary
15:29:28 - 02-Dec-25
Buy* 11 221.92p Ordinary
15:17:58 - 02-Dec-25
Sell* 1 219.40p Ordinary
15:17:57 - 02-Dec-25
Unknown* 0 218.00p SI Trade
10:15:04 - 02-Dec-25
Sell* 5,000 218.80p Ordinary
08:58:13 - 02-Dec-25
Sell* 2 219.50p Ordinary
08:00:09 - 02-Dec-25
Unknown* 0 226.00p SI Trade
08:00:08 - 02-Dec-25
Buy* 1 226.00p SI Trade
08:00:08 - 02-Dec-25
See more Hutchmed trades

Hutchmed (HCM) Share Price History

Time period:
to
Date Open High Low Close Volume
3rd Dec 2025 (Wed) 221.00 221.00 221.00 221.00 0
2nd Dec 2025 (Tue) 221.00 221.00 221.00 221.00 12,396
1st Dec 2025 (Mon) 220.00 226.00 220.00 225.00 26,651
28th Nov 2025 (Fri) 221.00 222.00 220.00 222.00 28,387
27th Nov 2025 (Thu) 213.00 217.00 213.00 215.50 32,155
26th Nov 2025 (Wed) 218.00 219.00 216.00 218.00 9,380
25th Nov 2025 (Tue) 215.00 218.00 214.00 216.00 23,814
24th Nov 2025 (Mon) 214.00 218.00 214.00 215.50 18,916
21st Nov 2025 (Fri) 217.00 218.00 217.00 217.00 20,131
20th Nov 2025 (Thu) 217.00 219.00 216.00 218.00 42,663
19th Nov 2025 (Wed) 232.00 232.00 217.00 222.00 8,117
18th Nov 2025 (Tue) 233.00 233.00 221.00 224.50 13,345
17th Nov 2025 (Mon) 228.00 235.00 228.00 229.00 27,559
14th Nov 2025 (Fri) 229.00 229.00 224.00 228.00 10,165
13th Nov 2025 (Thu) 224.00 232.00 224.00 231.00 9,490
12th Nov 2025 (Wed) 231.00 236.00 230.00 236.00 22,224
11th Nov 2025 (Tue) 235.00 235.00 232.00 232.00 22,640
10th Nov 2025 (Mon) 236.00 236.00 236.00 229.00 481
7th Nov 2025 (Fri) 222.00 236.00 222.00 236.00 5,216
6th Nov 2025 (Thu) 224.00 233.00 224.00 230.00 11,182
5th Nov 2025 (Wed) 235.00 235.00 235.00 228.50 164
4th Nov 2025 (Tue) 231.00 235.00 231.00 234.00 17,295
3rd Nov 2025 (Mon) 220.00 234.00 216.00 234.00 100,905
See more Hutchmed price history

Hutchmed (HCM) Regulatory News

Date Source Headline
28th Nov 2025 8:30 am RNS Total Voting Rights
27th Nov 2025 7:00 am RNS-R HUTCHMED Highlights Data at ESMO and ASH
5th Nov 2025 7:00 am RNS-R Enrollment Complete in SAFFRON Global Phase III
3rd Nov 2025 7:00 am RNS-R Updates from R&D Event
23rd Oct 2025 7:00 am RNS-R HUTCHMED Presents Data at AACR NCI EORTC
21st Oct 2025 9:30 am RNS Vesting of awards under Long Term Incentive Plan
14th Oct 2025 9:30 am RNS Appointment of Independent Non-executive Director
13th Oct 2025 7:05 am RNS-R Data to be Presented at the 2025 ESMO Congress
2nd Oct 2025 7:00 am RNS-R HUTCHMED Highlights Data to be Presented at ESMO
30th Sep 2025 9:30 am RNS Total Voting Rights
See more Hutchmed regulatory news

Hutchmed (HCM) Share News

Hutchmed completes Saffron trial enrolment, results due 2026

5th Nov 2025 11:48

(Alliance News) - Hutchmed China Ltd on Wednesday said patient enrolment has been completed for its phase 3 Saffron trial evaluating the combination of Orpathys and Tagrisso in certain lung cancer patients, with topline results expected in the first half of 2026. Read More

Hutchmed China CFO Cheng is interim CEO as CEO Su takes health leave

26th Aug 2025 09:14

(Alliance News) - Hutchmed China Ltd on Tuesday said Chief Executive Officer Weiguo Su will take a leave of absence for health reasons. Read More

Hutchmed China completes enrollment for phase three lung cancer trial

20th Aug 2025 10:55

(Alliance News) - Hutchmed China Ltd on Wednesday said it has completed patient enrollment of Sanovo, a phase three trial of Orpathys and Tagrisso. Read More

Hutchmed China interim profit jumps on joint venture stake disposal

7th Aug 2025 14:33

(Alliance News) - Hutchmed China Ltd on Thursday reported a jump in profit during the first half of its current financial year, and forecasts a full-year decline in its key Oncology/Immunology segment. Read More

UK earnings, trading statements calendar - next 7 days

31st Jul 2025 14:25

Read More

See more Hutchmed news
FTSE 100 Latest
Value9,701.80
Change-0.73

Login to your account

Forgot Password?

Not Registered